| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Breaux Castleman last filed a Form 4 in July 2020, as Director at IONS. Breaux Castleman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 19,183 shares of IONS. The IONS filings lean toward selling, a net 10,000 shares.
Breaux Castleman has 2 Form 4 filings on record from June 2020 to July 2020, all as Director at Ionis Pharmaceuticals (IONS), 2020.
The 8 reported transactions were 5 option exercises, 2 option or other derivative awards and 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $600K.
The only open-market sale was 10,000 shares of IONS at an average $60.00 on June 25, 2020, about $600K.
Shares as reported in the last Form 4 for each company; the most recent is from July 2020. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 25, 2020 | IONS Ionis Pharmaceuticals Inc | Director | Sale+OE | 10,000 | $60.00 | $600,000.00 | -39.7% |